# Phase 3 study comparing the use of docetaxel on an every‐3‐week versus weekly schedule in the treatment of metastatic breast cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-3-study-comparing-the-use-of-docetaxel-on-an-every-3-week-versus-weekly/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Edgardo Rivera,Jaime Mejia,Banu Arun,Rosnie B. Adinin,Ronald S. Walters,Abenaa M. Brewster,Kristine Broglio,Guosheng Yin,Bita Esmaeli,Gabriel N. Hortobágyi,Vicente Valero |
| Citations | 98 |
| DOI | 10.1002/cncr.23321 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cncr.23321 |
| OpenAlex ID | https://openalex.org/W2102880631 |
| PMID | 18300256 |
| Type | article |
| Year | 2008 |

## Paper authors

- [Jaime Mejia](https://scholariq.org/researchers/jaime-mejia/)

## Paper journal

- [Cancer](https://scholariq.org/journals/cancer/)

## Paper primary topic

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

## Paper topics

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.